slightly increases the exposure to roflumilast.

Study

▶ H2 receptor antagonists potentially decrease the exposure to

sofosbuvir. Adjust dose, see ledipasvir with sofosbuvir p. 628,

sofosbuvir with velpatasvir p. 629, and sofosbuvir with

velpatasvir and voxilaprevir p. 630.oStudy

▶ Cimetidine slightly increases the exposure to SSRIs (citalopram,

escitalopram). Adjust dose.oStudy

▶ Cimetidine slightly increases the exposure to SSRIs (paroxetine,

sertraline).oStudy

▶ Cimetidine is predicted to increase the risk of toxicity when

given with tegafur.rTheoretical

▶ Teriflunomide is predicted to increase the exposure to H2

receptor antagonists (cimetidine, famotidine).oStudy

▶ Cimetidine increases the concentration of theophylline. Adjust

dose.rStudy

▶ Cimetidine

o

increases the exposure to tricyclic antidepressants.

Study

▶ H2 receptor antagonists are predicted to decrease the

concentration of velpatasvir. Adjust dose, see sofosbuvir with

velpatasvir p. 629.oStudy

▶ Cimetidine slightly increases the exposure to venlafaxine.n

Study

▶ Cimetidine slightly increases the exposure to zolmitriptan.

Adjust zolmitriptan dose, p. 482.nStudy

Haloperidol → see TABLE 8 p. 1376 (hypotension), TABLE 9 p. 1377 (QTinterval prolongation), TABLE 11 p. 1377 (CNS depressant effects),

TABLE 10 p. 1377 (antimuscarinics)

FOOD AND LIFESTYLE Dose adjustment might be necessary if

smoking started or stopped during treatment.

▶ Antiepileptics (carbamazepine, fosphenytoin, phenobarbital,

phenytoin, primidone) decrease the concentration of

haloperidol. Adjust dose.oStudy → Also see TABLE 11

p. 1377

▶ Haloperidol potentially increases the risk of overheating and

dehydration when given with antiepileptics (zonisamide). Avoid

in children.rTheoretical

▶ Antifungals, azoles (itraconazole) increase the concentration of

haloperidol.oStudy

▶ Haloperidol is predicted to decrease the effects of dopamine

receptor agonists. Avoid.oTheoretical → Also see TABLE 8

p. 1376 → Also see TABLE 9 p. 1377 → Also see TABLE 10 p. 1377

▶ Enzalutamide decreases the concentration of haloperidol.

Adjust dose.oStudy

▶ Haloperidol potentially opposes the effects of glycerol

phenylbutyrate.oTheoretical

▶ Haloperidol is predicted to decrease the antihypertensive

effects of

Theoretical

guanethidine

→ Also see TABLE 8

. Monitor and adjust dose.

p. 1376

o ▶ HIV-protease inhibitors (ritonavir) are predicted to increase the

exposure to haloperidol.rTheoretical

▶ Haloperidol decreases the effects of levodopa.rStudy →

Also see TABLE 8 p. 1376

▶ Mitotane decreases the concentration of haloperidol. Adjust

dose.oStudy

▶ Rifampicin decreases the concentration of haloperidol. Adjust

dose.oStudy

▶ Haloperidol potentially decreases the effects of sodium

phenylbutyrate.oAnecdotal

▶ SSRIs (fluoxetine) increase the concentration of haloperidol.

Adjust dose.oAnecdotal

▶ SSRIs (fluvoxamine) increase the concentration of haloperidol.

Adjust dose.oStudy

▶ Venlafaxine

r

slightly increases the exposure to haloperidol.

Study → Also see TABLE 9 p. 1377 → Also see TABLE 11 p. 1377

Heparin (unfractionated) → see TABLE 16 p. 1379 (increased serum

potassium), TABLE 3 p. 1375 (anticoagulant effects)

▶ Ranibizumab increases the risk of bleeding events when given

with heparin (unfractionated).rTheoretical

Hepatitis B immunoglobulin → see immunoglobulins

HIV-protease inhibitors → see TABLE 9 p. 1377 (QT-interval

prolongation)

atazanavir. darunavir. fosamprenavir. lopinavir.ritonavir. saquinavir.tipranavir.

▶ Caution on concurrent use of atazanavir, lopinavir with

ritonavir, and ritonavir with drugs that prolong the PR

interval.

▶ Concurrent use of saquinavir with drugs that prolong the

PR interval is contra-indicated.

▶ Caution with concurrent use of tipranavir with drugs that

increase risk of bleeding.

▶ Tipranavir

r

slightly decreases the exposure to abacavir. Avoid.

Study

▶ HIV-protease inhibitors are predicted to increase the exposure

Study

to abemaciclib. Avoid or adjust abemaciclib dose, p. 967.r

▶ HIV-protease inhibitors (lopinavir, ritonavir, saquinavir) are

predicted to increase the exposure to afatinib. Separate

administration by 12 hours.oStudy

▶ Ritonavir

o

is predicted to decrease the exposure to agomelatine.

Theoretical

▶ Ritonavir

Study

decreases the exposure to albendazole.o ▶ HIV-protease inhibitors are predicted to markedly increase the

Study

exposure to aldosterone antagonists (eplerenone). Avoid.r

▶ HIV-protease inhibitors (ritonavir, saquinavir) are predicted to

increase the exposure to aliskiren.oTheoretical

▶ HIV-protease inhibitors increase the exposure to almotriptan.

nStudy

▶ HIV-protease inhibitors are predicted to moderately increase

the exposure to alpha blockers (alfuzosin, tamsulosin). Use with

caution or avoid.oStudy

▶ HIV-protease inhibitors are predicted to increase the exposure

to alpha blockers (doxazosin).oStudy

▶ HIV-protease inhibitors moderately increase the exposure to

alprazolam. Avoid.oStudy

▶ HIV-protease inhibitors (ritonavir, tipranavir) are predicted to

increase the exposure to amfetamines.rTheoretical

▶ Ritonavir decreases the exposure to aminophylline. Adjust

dose.oStudy

▶ Ritonavir is predicted to decrease the exposure to anaesthetics,

local (ropivacaine).oTheoretical

▶ Antacids are predicted to decrease the absorption of

atazanavir. Atazanavir should be taken 2 hours before or

1 hour after antacids.rTheoretical

BNF 78 H2 receptor antagonists — HIV-protease inhibitors 1463

Interactions | Appendix 1

A1

HIV-protease inhibitors (continued)

▶ Antacids are predicted to decrease the absorption of

tipranavir. Separate administration by 2 hours.oStudy

▶ HIV-protease inhibitors are predicted to increase the exposure

to antiarrhythmics (amiodarone). Avoid.rTheoretical → Also

see TABLE 9 p. 1377

▶ HIV-protease inhibitors are predicted to increase the exposure

to antiarrhythmics (disopyramide).rTheoretical → Also see

TABLE 9 p. 1377

▶ HIV-protease inhibitors very markedly increase the exposure to

antiarrhythmics (dronedarone). Avoid.rStudy → Also see

TABLE 9 p. 1377

▶ Ritonavir is predicted to increase the exposure to

antiarrhythmics

r

(flecainide). Avoid or monitor side effects.

Theoretical

▶ HIV-protease inhibitors are predicted to increase the exposure

to antiarrhythmics (lidocaine). Avoid.rStudy

▶ HIV-protease inhibitors are predicted to increase the exposure

to

r

antiarrhythmics (propafenone). Monitor and adjust dose.

Study

▶ HIV-protease inhibitors are predicted to increase the exposure

to anticholinesterases, centrally acting (galantamine). Monitor

and adjust dose.oStudy

▶ HIV-protease inhibitors are predicted to increase the exposure

to antiepileptics (carbamazepine) and antiepileptics

(carbamazepine) are predicted to decrease the exposure to

HIV-protease inhibitors

Theoretical

. Monitor and adjust dose.r

▶ HIV-protease inhibitors are predicted to affect the exposure to

antiepileptics (fosphenytoin, phenytoin) and antiepileptics

(fosphenytoin, phenytoin) decrease the concentration of HIVprotease inhibitors.rTheoretical

▶ Ritonavir slightly decreases the exposure to antiepileptics

(lamotrigine).rStudy

▶ HIV-protease inhibitors are predicted to very slightly increase

the exposure to antiepileptics (perampanel).nStudy

▶ HIV-protease inhibitors are predicted to affect the

concentration of antiepileptics (phenobarbital, primidone) and

antiepileptics (phenobarbital, primidone) are predicted to

decrease the concentration of

Theoretical

HIV-protease inhibitors.r

▶ Ritonavir is predicted to decrease the concentration of

antiepileptics (valproate).rAnecdotal

▶ Antifungals, azoles (fluconazole) slightly increase the exposure

to tipranavir. Avoid or adjust dose.oStudy

▶ Antifungals, azoles (miconazole) are predicted to increase the

concentration of HIV-protease inhibitors. Use with caution and

adjust dose.oTheoretical

▶ Antifungals, azoles (posaconazole) are predicted to increase the

exposure to HIV-protease inhibitors.oStudy

▶ HIV-protease inhibitors are predicted to increase the exposure

to antifungals, azoles (isavuconazole). Avoid or monitor side

effects.rStudy

▶ HIV-protease inhibitors are predicted to increase the exposure

to antifungals, azoles (itraconazole). Use with caution and

adjust dose.rStudy

▶ HIV-protease inhibitors are predicted to increase the exposure

to antifungals, azoles (ketoconazole). Use with caution and

adjust dose.oStudy

▶ HIV-protease inhibitors are predicted to affect the exposure to

antifungals, azoles (voriconazole) and antifungals, azoles

(voriconazole) potentially affect the exposure to HIV-protease

inhibitors.rStudy → Also see TABLE 9 p. 1377

▶ HIV-protease inhibitors are predicted to increase the exposure

to antihistamines, non-sedating (mizolastine). Avoid.rStudy

▶ HIV-protease inhibitors are predicted to increase the exposure

to

Study

antihistamines, non-sedating (rupatadine). Avoid.o ▶ HIV-protease inhibitors decrease the exposure to antimalarials

(atovaquone). Avoid if boosted with ritonavir.oStudy

▶ HIV-protease inhibitors are predicted to increase the

concentration of antimalarials (piperaquine).rTheoretical

▶ HIV-protease inhibitors are predicted to decrease the exposure

to antimalarials (proguanil). Avoid.oStudy

▶ HIV-protease inhibitors are predicted to affect the exposure to

antimalarials (quinine).rStudy → Also see TABLE 9 p. 1377

▶ HIV-protease inhibitors are predicted to increase the exposure

to apalutamide.nStudy → Also see TABLE 9 p. 1377

▶ Ritonavir is predicted to increase the exposure to apixaban.

Avoid.rTheoretical

▶ HIV-protease inhibitors are predicted to markedly increase the

exposure to aprepitant.oStudy

▶ HIV-protease inhibitors are predicted to slightly increase the

exposure to

o

Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

Kana Brax Laberax

TRIPASS XR تري باس

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

CELEPHI 200 MG, Gélule

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more